Counterfeiters lurk in free trade zones

Counterfeit drugmakers have found some unlikely allies: free trade zones. Set up by governments to promote trade, these zones have little regulatory oversight, and tariffs are waived. So it's relatively simple for counterfeiters to disguise the source of a drug, or to make and sell tainted products, according to a new investigation by the New York Times.

Recently, a stash of fake drugs was seized in a free trade zone in Dubai; the meds were destined for Americans who believed they were buying drugs from Canada, via an Internet pharmacy. It's a typical case of counterfeiters using one or more free trade zones to avoid detection.

Counterfeiting, of course, is a big threat to Big Pharma, because most of the fake drugs are tainted knockoffs of big-time brand name meds. And for patients, the fakes can be deadly.

- read the article from the New York Times

Related Articles:
Counterfeit drugs plaguing Big Pharma. Report
Chinese pharma recalls counterfeit drug. Report
FDA can't guarantee drug safety. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.